These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9301290)

  • 1. [Prevention of post-transfusion graft versus host disease by irradiating blood products with X-ray or gamma-ray].
    Tanaka S
    Nihon Rinsho; 1997 Sep; 55(9):2277-81. PubMed ID: 9301290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of post-transfusion graft-versus-host disease.
    Tasaki T; Ohto H; Abe R
    Fukushima J Med Sci; 1993 Dec; 39(2):109-11. PubMed ID: 7927133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-ray irradiation effectively inactivated lymphocytes in transfusion in vivo monitored by the bioluminescence transfusion-associated graft-versus-host disease model.
    Peng D; Bai W; Zhang C; Chang X; Ma P; Wang X; Sun S; Zhan L
    Vox Sang; 2024 Mar; 119(3):181-192. PubMed ID: 38226529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease?
    Fast LD; Nevola M; Tavares J; Reddy HL; Goodrich RP; Marschner S
    Transfusion; 2013 Feb; 53(2):373-81. PubMed ID: 22612327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for irradiation of blood and blood components to prevent post-transfusion graft-vs.-host disease in Japan.
    Asai T; Inaba S; Ohto H; Osada K; Suzuki G; Takahashi K; Tadokoro K; Minami M
    Transfus Med; 2000 Dec; 10(4):315-20. PubMed ID: 11123816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of X-ray vs. gamma irradiation of CPDA-1 red cells.
    Janatpour K; Denning L; Nelson K; Betlach B; Mackenzie M; Holland P
    Vox Sang; 2005 Nov; 89(4):215-9. PubMed ID: 16262754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion associated graft versus host disease.
    Anwar M; Bhatti FA
    J Ayub Med Coll Abbottabad; 2003; 15(3):56-8. PubMed ID: 14727344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion-associated graft-versus-host disease.
    Castro G; Merkel PA; Giclas HE; Gibula A; Andersen GE; Corash LM; Lin JS; Green J; Knight V; Stassinopoulos A
    Transfusion; 2018 Jun; 58(6):1506-1515. PubMed ID: 29607502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of transfusion-associated graft-vs-host disease.
    Holland PV
    Arch Pathol Lab Med; 1989 Mar; 113(3):285-91. PubMed ID: 2645855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developments in the prevention of transfusion-associated graft-versus-host disease.
    Fast LD
    Br J Haematol; 2012 Sep; 158(5):563-8. PubMed ID: 22734439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of Irradiation Practice for the Prevention of Transfusion-Associated Graft-versus-Host Disease.
    Pritchard AE; Shaz BH
    Arch Pathol Lab Med; 2016 Oct; 140(10):1092-7. PubMed ID: 27684981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transfusion-associated graft-vs-host disease].
    Lillevang ST; Kristensen T
    Ugeskr Laeger; 1992 Oct; 154(43):2964-8. PubMed ID: 1462384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transfusion-associated graft-versus-host disease].
    Bojanić I; Cepulić BG
    Lijec Vjesn; 2004; 126(1-2):39-47. PubMed ID: 15526751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of visualized highly sensitive new chemical dosimeter: application to blood irradiation].
    Sekine H; Takiue M; Yoshizawa Y; Natake T; Kanehira C
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Sep; 59(11):526-8. PubMed ID: 10536449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft-versus-host disease: introduction and prospect.
    Ohto H; Suzuki H; Abe R
    Fukushima J Med Sci; 1993 Dec; 39(2):63-7. PubMed ID: 7927136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is pathogen reduction an acceptable alternative to irradiation for risk mitigation of transfusion-associated graft versus host disease?
    Li M; Irsch J; Corash L; Benjamin RJ
    Transfus Apher Sci; 2022 Apr; 61(2):103404. PubMed ID: 35288055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of 66 patients definitive with transfusion-associated graft-versus-host disease and the effect of universal irradiation of blood.
    Uchida S; Tadokoro K; Takahashi M; Yahagi H; Satake M; Juji T
    Transfus Med; 2013 Dec; 23(6):416-22. PubMed ID: 24274074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion-associated graft-versus-host disease.
    Dwyre DM; Holland PV
    Vox Sang; 2008 Aug; 95(2):85-93. PubMed ID: 18544121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of gamma irradiation versus white cell reduction on the mixed lymphocyte reaction.
    Dzik WH; Jones KS
    Transfusion; 1993 Jun; 33(6):493-6. PubMed ID: 8516792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of graft-versus -leukemia activity of gamma-ray irradiated haplomismatched donor lymphocytes infusion].
    Zhang L; Guo K; Dong B; Luo Q
    Zhonghua Xue Ye Xue Za Zhi; 2000 Feb; 21(2):81-3. PubMed ID: 11876964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.